Herein we report the synthesis of 13-, 14-and 15-membered cyclic lactams, using Grubbs' RCM method in 25, 52 and 46% yields respectively. The cis-enamide functional group was successfully introduced into these cyclic lactams by syn sulfoxide elimination The synthetic cyclic lactams resemble natural cyclic peptides. Our synthetic methodology provides a simple route to making medium-sized cyclic lactams that could be used as models to mimic the β-turn in natural proteins, an important marker in understanding their biological activity. 
Introduction
Over the past five decades, about 500 cyclopeptides have been isolated from over 120 species. A large number of 13-, 14-and 15-membered cyclopeptides have been isolated from plants belonging to the Rhamnaceae, Sterculiaceae, Pandaceae, Rubiaceae, Urticaceae, Hymenocardiaceae, and Celastraceae families. [1] [2] [3] [4] [5] [6] We are interested in the chemistry of the cyclic lactams with an enamide (styrylamide) functionality in their cyclic structure, e.g. zizyphine A, 7 or a secondary alcohol group, which probably is the precursor to the styrylamide through dehydration, as in pandamine (Figure 1 ). 8 Plant cyclopeptides have shown various bioactivities, such as antitumor, antibacterial, antifungal, antiHIV, antimalarial, antiplasmodial, insecticidal, antiplatelet, cyclooxygenase and tyrosine inhibiting activities. [9] [10] [11] [12] [13] Our interest in the chemistry of enamides (styrylamides) arose from our ongoing program of study of the synthesis and biological activity of acyclic enamides, like tuberine and amathamide A (Figure 2 ). [14] [15] [16] [17] [18] Many of the acyclic enamides isolated from marine sources as ascidians, [19] [20] [21] [22] [23] microorganisms, [24] [25] [26] fungal and higher plants [27] [28] [29] [30] [31] exhibit a variety of pharmacological activities. 25, 26, 32, 33 Especially the macrolides salicylihalamides A and B, 34, 35 apicularen A and B 36 and lobatamide A-F 37, 38 isolated from marine sponge Haliclona sp., Chondromyces sp. (myxobacteria) and tunicates, respectively. Salicylihalamides A, B and lobatamides are highly potent cytotoxic macrolides, incorporating salicylic acid, a 12-membered lactone ring and an enamide side-chain (trans A, cis B) ( Figure 2 ). Salicylihalamide A and lobatamide A display potent cytotoxicity in the NCI 60-cell line human tumor assay, and it is suggested that these compounds may act by a novel mechanism of action. 39 Recently, it has been reported that salicylate enamide macrolides selectively inhibit the Vo sector of the V-ATPase through Nacyliminium ion generated from N-acyl enamines under acidic conditions. 39 Figure 4 shows how the acyliminium is captured by a nucleophilic amino acid side-chain, and subsequently undergoes irreversible hydrolysis. A study on the structure-activity relationships (SAR) of (-)-salicylihalamide A reported by Barbander and co-workers, revealed that the characteristic N-acyl enamine functionality is essential for the biological activity. 40, 41, 42 This mechanistic route via the enamide ATPase protein interaction, its biological implications, and its stereochemistry attracted our attention and prompted us to develop a simple and efficient synthetic route to the acyclic enamide tuberine and its analogs, in order to study in detail their biological properties. Biologically active macrocylic lactams and enamides have been reported, isolated from natural sources. The cryptophycins are a family of highly cytotoxic, cyclic depsipeptides and are among the the most potent agents, and their binding to tubulin is very strong and poorly reversible. Many cryptophycins have been isolated fron Cyanobacterium nostoc sp. 43 Cryptophycin 52 ( Figure 4 ) was produced by total chemical synthesis and it destroys microtubules in vascular smooth muscle cells. Ixabepilone is a semisynthetic epothilone B analogue, which acts like Paclitaxel as a microtubule stabilizing agent. It is used in the treatment of aggresive metastatic or locally advanced breast cancer. 44 Tanespimycin is a derivative of the antibiotic geldanamycin that is being studied in the treatment of cancer, specifically in young patients with certain types of leukemia or solid tumors, especially kidney tumors. It works by inhibiting Hsp90, which is expressed in those tumors, and it belongs to the family of drugs called antitumor antibiotics. 45 Finally, sagamilactam is a polyunsaturated and polyoxygenated macrocyclic lactam containing diene, triene and tetraene conjugated olefins and a decalin moiety which has antitrypanosomal activity. In our synthesis of tuberine and other simple acyclic enamides, the method we used involved thermal synelimination of β-sulfoxide derived from an amide to generate the enamide functional group. [15] [16] [17] [18] This method was successfully employed in the synthesis of some naturally occurring N-acylenamides. 16 In most cases when the N-acyl is a formyl group, the Z-N-alkenylformamides were the major product. The naturally occurring tuberine also exhibited a similar Z:E ratio. In addition, 1 H NMR signals for the two stereoisomers due to the conformers arising from restricted amide bond rotation were encountered, which led us to calculate a rotational barrier of 19 kcal/mol using 2D EXY NMR. Since many of the naturally occurring enamides also have a cis-enamide, it was of interest to study in depth the physical properties of cis-enamides. The cis-N-(β-2,6-difluorostyryl)formamide was selected as a model. The NMR studies revealed a rotational barrier for the cisenamide with the same magnitude as the trans-enamide. However, the X-ray structure of the trans-trans-N-(β-4-methoxystyryl)formamide (tuberine) showed that the benzene π-plane was coplanar to the π-enamide bond (Figure 5a) , while in the cis-enamide N-(β-2,6-difluorostyryl)formamide (Figure 5b ) the styrylamide π-
Results and Discussion
Our synthetic strategy for the high membered macrocycles is shown in Scheme 1. It started with the alkylation of an appropriately substituted hydroxybenzaldehyde 1 with allyl bromide under basic conditions. The allyloxybenzaldehydes 2 were subjected to an addition of nitromethane, followed by a subsequent Michael addition of thiophenol to nitrostyrenes 3 to give nitro sulfides 4. The nitro group was reduced to amino giving compounds 5, and these were then derivatized with a suitable n-alkenyl carboxylic acid to give the amides 6-8 with a diene functionality, which then were ring closed by the RCM method using a GrubbsHoveyda first generation catalyst to give the macrocyclic compounds 9-11 in very good yields. The sulfide group was oxidized to sulfoxide and the sulfoxides subjected to thermal elimination to give the cis-enamides 12-14 in good yields. This methodology is straightforward compared to the selenocyanate oxidative elimination reported independently by Schmidt and Joullie in the synthesis of the cyclopeptide alkaloids franguline A and nummularine F, respectively. 47 Our initial goal was to find a suitable methodology to construct the required ring system, followed by a syn elimination of the sulfoxide to generate the enamide functional group. Among the various methods known for making cyclopeptides, ethers and esters, catalytic ring-closing olefin metathesis is by far the simplest and most useful tool for making medium-sized ring compounds.
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9a H H, n = 2 9b Br Br, n = 2 10a H H, n = 3 11a H H, n = 4 11b Br Br, n = 4 
Conclusions
We have synthesized 13-, 14-and 15-membered cis-enamide macrocycles using Grubbs RCM method in 25, 52 and 46% overall yields, respectively. The cis-enamide functional group was successfully introduced into these cyclic lactams by a syn sulfoxide elimination. This synthetic methodology provides a simple route to making medium-sized cyclic lactams. These medium-sized cyclic lactams could be used as models to mimic the β-turn in natural proteins, an important marker in understanding their biological activity.
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Experimental Section
General. All reagents were purchased in the highest quality available and were used without further purification.
H and 13
C NMR spectra were recorded using a Varian 500 MHz Spectrometer in CDCl3 with TMS as internal standard and 200 MHz. The chemical shifts are expresed in ppm and the coupling constants (J) in Hertz. Electronic impact mass spectra were obtained by direct insertion in Agilent 5975C mass spectrometer. Infrared spectra were recorded on a Spectrum FT-IR 1600 spectrophotometer. Melting points were determined on a Fisher-Johns melting point apparatus and were corrected.
2,4-Dibromo-5-hydroxybenzaldehyde (1b).
To a solution of 3-hydroxybenzaldehyde 1a (40.9 mmol, 5.0 g) in CHCl3 (100 mL) was added bromine (81.7 mmol, 4.2 mL). The resulting solution was stirred at rt for 3 d. The excess bromine was removed with a saturated solution of sodium thiosulfate (20 mL), the organic phase was washed with water and dried over anhydrous Na2SO4. Removal of solvent gave a solid which was recrystallized from acetic acid to give 1b (10.5 
3-Allyloxybenzaldehyde (2a).
To a solution of 3-hydroxybenzaldehyde 1a (81.9 mmol, 10.0 g) and K2CO3 (1.5 g) in DMF (100.0 mL) was added allyl bromide (7.8 mL) and the mixture was stirred for 3 h at rt. The reaction mixture was quenched with water (50 mL) and the organic phase was extracted into Et2O (3×100 mL), dried over Na2SO4 and the solvent removed at reduced pressure to give a yellow liquid 2a (11.0 g, 83%): FTIR (KBr) 3071, 2818, 1697 cm (27) , 223 (50) .
(E)-1-(Allyloxy)-3-(2-nitrovinyl)benzene (3a)
. To a solution of 2a (12.3 mmol, 2.0 g) in glacial AcOH (20 mL) was added NH4OAc (0.4 g) and nitromethane (2.0 mL). The solution was heated at reflux with magnetic stirring for 1 h. The mixture was cooled to rt, the resulting dark yellowish precipitate was collected by filtration and was washed with water. The solid was dissolved in CH 2 Cl 2 (40.0 mL), filtered through a plug of silica and then the organic phase was dried over anhydrous Na2SO4 and concentrated under reduced pressure to give a yellowish solid (1.8 
2-(3-Allyloxyphenyl)-2-phensulfanylethanamine (5a).
A stirred mixture of 4a (31.7 mmol, 10.0 g), zinc (316 mmol, 20.6 g) and AcOH (80 mL), was cooled in an ice/water bath, and concentrated HCl (67 mL) added dropwise and then stirred overnight at rt. The highly acidic solution was then treated with NH4OH (2 N) until the pH was about 10. The oily precipitate formed was extracted with CH2Cl2 (2×100 mL), the extact dried with Na2SO4 and concentrated to give the amine as a yellow oil (3.6 g, 40%). The crude amine was then used in the next step without further purification. FTIR (ATR): 3367, 3064, 2917, 1582, 1479 cm 60 (m, 1H), 2.29 (m, 2H) 
N-(2-(5-allyloxy-2,4-dibromophenyl)-2-(phenylthio)ethyl)pent-4-enamide (6b).
Compound 6b was synthesized from 5b (1.5 mmol, 0.7 g), using the same procedure as for compound 6a. 154.2, 138.1, 136.4, 136.1, 132.3, 132.2, 131.7, 128.8 N-(2-(3-allyloxyphenyl)-2-(phenylthio)ethyl) hex-5-enamide 7a. To a well stirred and ice cooled solution of DCC (7.7 mmol, 1.6 g), under argon, DMAP (0.05 g) and 5-hexenoic acid (7.7 mmol, 0.9 mL) in dry THF (100 mL) was added the amine 5a (7.7 mmol, 2.2 g). The mixture was strirred at rt for 24 h then it was filtered, dried with Na2SO4 and concentrated. The residue was purified using circular chromatography eluting with CH2Cl2/MeOH (97:3) to afford the product as a yellow liquid (2. 11-phenylsulfanyl-2-oxa-9-azabicyclo[10.3.1]hexadeca-1(16),4E,12,14-tetraen-8-one (9a) . To solution of diene 6a (80.0 mg, 0.2 mmol) in 55 mL of dry CH2Cl2 (0.004 M) was added the Hoveyda-Grubbs catalyst (9.0 mg, 0.014 mmol) and refluxed for 12 h. The reaction was carried out in an open system and to remove ethylene from the system a very gentle flow of argon was used. Then, the reaction mixture was filtered through a short fluorisil pad to remove the catalyst residues. The solvent was evaporated under reduced pressure and the crude product was purified using circular chromatography to give the macrocycle product 171.8, 157.1, 139.6, 134.1, 133.9, 131.5, 130.0, 129.1, 127.8, 127.3, 119.6, 117.9, 116.9, 69.1, 51.0, 44.9 13,15-Dibromo-11-phenylsulfanyl-2-oxa-9-azabicyclo[10.3.1]hexadeca-(16),4E,12,14-tetraen-8-one (9b). Compound 9b was synthesized using the same procedure for compound 9a using diene 6b (55. -1-(18),4,14,16-tetraen-10-one (11b) . To solution of diene 8b (118.4 mg, 0.214 mmol) in 215 mL of dry CH2Cl2 (0.001 M) was added the HoveydaGrubb´s catalyst (6.7 mg, 0.011 mmol) and the mioxture heated at reflux for 12 h. The reaction was carried out in an open system and to remove ethylene from the system a very gentle flow of Ar was used. Then, the reaction mixture was filtered through a short fluorisil pad to remove the catalyst residues. The solvent was evaporated under reduced pressure and the crude product was purified using circular chromatography to give the macrocyclic product (113 mg, 80% yield). CDCl3): δ 173.0, 138.3, 137.2, 137.0, 135.4, 133.2, 131.9, 131.3, 129.2, 129.1 -1(16),4E,11Z(10),12,14-penten-8-one (12a) . To a solution of sulfide 9a (70 mg, 0.21 mmol) in MeOH (5.0 mL) were added dropwise 5.0 mL of an aqueous solution of sodium periodate (88.3 mg, 0.42 mmol) at rt and the mixture stirred for 2 h. The mixture was extracted with CH2Cl2 (3×5 mL) and the combined organic phase was dried with Na 2 SO 4 , filtered and the solvent was evaporated to give the sulfoxide as a colorless oil. To a solution of sulfoxide in toluene (20 mL) was added K2CO3 (189 mg, 1.4 mmol) and stirred at reflux for 3 h. The solvent was evaporated and the residue was dissolved with CH2Cl2 (20 mL) and washed with brine. The organic phase was dried with Na2SO4, filtered and the solvent was evaporated to give a crude product that was purified by circular chromatography to give a colorless oil (44.6 mg, 94% yield); FTIR (KBr) 3292, 3062, 2922, 1655, 1635, 1534 cm 
